Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (NV): Acquisition completed of a Las Vegas-based cannabis operator

Jushi Holdings' subsidiary, Production Excellence has completed the acquisition of 100% of the equity of Franklin Bioscience NV (FBS Nevada). FBS Nevada holds medical and adult-use cannabis cultivation, processing and distribution licenses issued by the Nevada Cannabis Control Board and currently operates cultivation, production and distribution facilities in North Las Vegas. Jushi also owns the real estate associated with FBS Nevada’s facilities in North Las Vegas. The facilities acquired include two adjacent buildings with cultivation, manufacturing and distribution capabilities.

In July 2019, the Jushi’s subsidiary, Production Excellence, entered into the Nevada market under a management services agreement with FBS Nevada. FBS Nevada operates one of the two 7,500-square-foot adjacent facilities and has upgraded the facility with state-of-the-art, indoor, double-stacked cultivation that yields approximately 2,500 pounds of high-quality dry flower per year. 

To better serve the Nevada market, FBS Nevada plans to connect the two facilities to create a single production space for a total of approximately 16,600 square feet. The expansion is expected to more than double cultivation capacity and incorporate a CO2 and hydrocarbon extraction facility with a full kitchen to ensure a broad assortment of products across all categories.

“We are extremely pleased to complete this acquisition and solidify our presence in Nevada, particularly the Greater Las Vegas region,” said Jim Cacioppo, CEO, chairman and founder of Jushi. “We look forward to continuing to serve the Nevada wholesale market with high-quality flower and a full suite of cannabis brands including infused products. While Nevada, and specifically Las Vegas, has been impacted by the COVID-19 pandemic, we see great opportunities with the expansion of our facility and exploring attractive M&A prospects as we look to expand our footprint in this strategic limited license market.”

For more information:
Jushi
+1 (561) 617 9100
investors@jushico.com    
jushico.com    

 

Publication date: